BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34198153)

  • 1. Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene.
    Huang D; Zhang D; Chen SC; Aung-Htut MT; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Fletcher S; Wilton SD; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102448. PubMed ID: 34198153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line from a patient with Stargardt disease caused by biallelic c.[5461-10T>C;5603A>T];[6077T>C] mutations in the ABCA4 gene.
    Huang D; Zhang D; Chen SC; Thandar Aung-Htut M; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Fletcher S; Wilton SD; McLenachan S; Chen FK
    Stem Cell Res; 2021 Jul; 54():102439. PubMed ID: 34214897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4.
    Jennings L; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2020 Oct; 48():101947. PubMed ID: 32810830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations.
    Riera M; Patel A; Burés-Jelstrup A; Corcostegui B; Chang S; Pomares E; Corneo B; Sparrow JR
    Stem Cell Res; 2019 Apr; 36():101389. PubMed ID: 30798147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy.
    Claassen JN; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 Jan; 34():101352. PubMed ID: 30634128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an iPSC line (RMCGENi020-A) from a patient with Stargardt disease harboring the recurrent intronic ABCA4 variant c.4253+43G>A.
    Suárez-Herrera N; Leijsten N; Albert S; Bax NM; Hoyng CB; Cremers FPM; Garanto A; Collin RWJ
    Stem Cell Res; 2023 Dec; 73():103252. PubMed ID: 37979432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
    Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200.
    Zhang D; McLenachan S; Chen SC; Zaw K; Alziyadat Y; Zhang X; Lamey TM; Thompson JA; McLaren TL; Mellough C; De Roach JN; Chen FK
    Stem Cell Res; 2021 Mar; 51():102154. PubMed ID: 33429167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of the iPSC line CUIMCi005-A from a patient with Stargardt disease for retinal organoid culture.
    Su PY; Lee W; Zernant J; Tsang SH; Nagasaki T; Corneo B; Allikmets R
    Stem Cell Res; 2022 Dec; 65():102973. PubMed ID: 36455383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of iPSC lines from three Stargardt patients carrying bi-allelic ABCA4 variants.
    Karjosukarso DW; Bukkems F; Duijkers L; Leijsten N; Hoyng CB; Collin RWJ
    Stem Cell Res; 2023 Sep; 71():103164. PubMed ID: 37441824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene.
    McLenachan S; Wong EYM; Zhang X; Leith F; Moon SY; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; Atlas MD; Dilley RJ; Chen FK
    Stem Cell Res; 2019 Apr; 36():101420. PubMed ID: 30904819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense Oligonucleotide Screening to Optimize the Rescue of the Splicing Defect Caused by the Recurrent Deep-Intronic
    Garanto A; Duijkers L; Tomkiewicz TZ; Collin RWJ
    Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31197102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of three isogenic control lines from patient-derived iPSCs carrying bi-allelic ABCA4 variants underlying Stargardt disease.
    Karjosukarso DW; Bukkems F; Duijkers L; Leijsten N; Collin RWJ
    Stem Cell Res; 2023 Sep; 71():103169. PubMed ID: 37480818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-autonomous lipid-handling defects in Stargardt iPSC-derived retinal pigment epithelium cells.
    Farnoodian M; Bose D; Khristov V; Susaimanickam PJ; Maddileti S; Mariappan I; Abu-Asab M; Campos M; Villasmil R; Wan Q; Maminishkis A; McGaughey D; Barone F; Gundry RL; Riordon DR; Boheler KR; Sharma R; Bharti K
    Stem Cell Reports; 2022 Nov; 17(11):2438-2450. PubMed ID: 36306781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Rescue of Splice Defects Caused by Two Neighboring Deep-Intronic ABCA4 Mutations Underlying Stargardt Disease.
    Albert S; Garanto A; Sangermano R; Khan M; Bax NM; Hoyng CB; Zernant J; Lee W; Allikmets R; Collin RWJ; Cremers FPM
    Am J Hum Genet; 2018 Apr; 102(4):517-527. PubMed ID: 29526278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic architecture of Stargardt macular dystrophy (STGD1): a longitudinal 40-year study in a genetic isolate.
    Green JS; O'Rielly DD; Pater JA; Houston J; Rajabi H; Galutira D; Benteau T; Sheaves A; Abdelfatah N; Bautista D; Whelan J; Young TL
    Eur J Hum Genet; 2020 Jul; 28(7):925-937. PubMed ID: 32467599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterising splicing defects of ABCA4 variants within exons 13-50 in patient-derived fibroblasts.
    Huang D; Thompson JA; Chen SC; Adams A; Pitout I; Lima A; Zhang D; Jeffery RCH; Attia MS; McLaren TL; Lamey TM; De Roach JN; McLenachan S; Aung-Htut MT; Fletcher S; Wilton SD; Chen FK
    Exp Eye Res; 2022 Dec; 225():109276. PubMed ID: 36209838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Sex With Frequent and Mild ABCA4 Alleles in Stargardt Disease.
    Runhart EH; Khan M; Cornelis SS; Roosing S; Del Pozo-Valero M; Lamey TM; Liskova P; Roberts L; Stöhr H; Klaver CCW; Hoyng CB; Cremers FPM; Dhaenens CM;
    JAMA Ophthalmol; 2020 Oct; 138(10):1035-1042. PubMed ID: 32815999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
    Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
    Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.